rs11683424

Variant names:

• chr2-25266263-C-T
• rs11683424
• NM_022552.5:c.639+8678G>A

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_Strong BA1

The NM_022552.5(DNMT3A):​c.639+8678G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.137 in 152,246 control chromosomes in the GnomAD database, including 1,648 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

• Frequency: Genomes: 𝑓 0.14 (1648 hom., cov: 32)
• Consequence: DNMT3A NM_022552.5 intron
• Clinical Significance: Not reported in ClinVar
• Conservation: PhyloP100: -0.582
• Publications: 16 publications found

Genes affected

DNMT3A (HGNC:2978): (DNA methyltransferase 3 alpha) CpG methylation is an epigenetic modification that is important for embryonic development, imprinting, and X-chromosome inactivation. Studies in mice have demonstrated that DNA methylation is required for mammalian development. This gene encodes a DNA methyltransferase that is thought to function in de novo methylation, rather than maintenance methylation. The protein localizes to the cytoplasm and nucleus and its expression is developmentally regulated. [provided by RefSeq, Mar 2016]

DNMT3A Gene-Disease associations (from GenCC):

• Tatton-Brown-Rahman overgrowth syndrome

  Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Illumina, Ambry Genetics, ClinGen, G2P, Orphanet, Labcorp Genetics (formerly Invitae)
• Heyn-Sproul-Jackson syndrome

  Inheritance: AD Classification: STRONG, MODERATE, LIMITED Submitted by: Ambry Genetics, ClinGen, G2P, Labcorp Genetics (formerly Invitae)

ACMG classification

Our verdict: Benign. The variant received -12 ACMG points.

• BP4: Computational evidence support a benign effect (BayesDel_noAF=-0.77).
• BA1: GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.178 is higher than 0.05.

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	MANE	Protein	UniProt
DNMT3A	NM_022552.5	c.639+8678G>A		intron_variant	Intron 6 of 22	ENST00000321117.10	NP_072046.2

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	TSL	MANE	Protein	Appris	UniProt
DNMT3A	ENST00000321117.10	c.639+8678G>A		intron_variant	Intron 6 of 22	1	NM_022552.5	ENSP00000324375.5
DNMT3A	ENST00000264709.7	c.639+8678G>A		intron_variant	Intron 6 of 22	1		ENSP00000264709.3
DNMT3A	ENST00000380756.7	n.639+8678G>A		intron_variant	Intron 6 of 23	1		ENSP00000370132.3

Frequencies

GnomAD3 genomes AF: 0.137 AC: 20793 AN: 152128 Hom.: 1648 Cov.: 32

Gnomad AFR AF: 0.0887

Gnomad AMI AF: 0.147

Gnomad AMR AF: 0.0866

Gnomad ASJ AF: 0.0655

Gnomad EAS AF: 0.0804

Gnomad SAS AF: 0.101

Gnomad FIN AF: 0.187

Gnomad MID AF: 0.0411

Gnomad NFE AF: 0.180

Gnomad OTH AF: 0.122

We have no GnomAD4 exomes data on this position. Probably position not covered by the project.

GnomAD4 genome AF: 0.137 AC: 20799 AN: 152246 Hom.: 1648 Cov.: 32 AF XY: 0.134 AC XY: 10005 AN XY: 74424

African (AFR) AF: 0.0886 AC: 3682 AN: 41552

American (AMR) AF: 0.0867 AC: 1326 AN: 15300

Ashkenazi Jewish (ASJ) AF: 0.0655 AC: 227 AN: 3468

East Asian (EAS) AF: 0.0806 AC: 418 AN: 5184

South Asian (SAS) AF: 0.101 AC: 488 AN: 4820

European-Finnish (FIN) AF: 0.187 AC: 1984 AN: 10592

Middle Eastern (MID) AF: 0.0442 AC: 13 AN: 294

European-Non Finnish (NFE) AF: 0.180 AC: 12271 AN: 68012

Other (OTH) AF: 0.121 AC: 256 AN: 2114

Alfa AF: 0.158 Hom.: 3964

Bravo AF: 0.125

Asia WGS AF: 0.0830 AC: 288 AN: 3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name	Calibrated prediction	Score	Prediction
BayesDel_noAF	Benign	-0.77
CADD	Benign	4.2
DANN	Benign	0.77
PhyloP100		-0.58
Mutation Taster		=100/0	polymorphism (auto)

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Other links and lift over

dbSNP: rs11683424; hg19: chr2-25489132;